Venus Remedies Limited has informed the Exchange regarding 'Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011'.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Limited has filed its yearly disclosure under SEBI's Takeover Regulations. Pawan Chaudhary, on behalf of all promoters and promoter group members (including Manu Chaudhary, Peeyush Jain, Ashutosh Jain, Akshansh Chaudhary, and Sunev Pharma Solutions Pvt Ltd), has declared that no new share encumbrances were created or released during FY 2025-26. The disclosure confirms that as of March 31, 2026, no equity shares held by the promoters and promoter group are pledged or encumbered. This is a standard regulatory compliance filing that provides transparency on promoter shareholding status.
A positive signal for retail investors as it confirms promoters have not pledged their shares, indicating no immediate risk of forced share sales and healthy promoter confidence in the company.